Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Cash from Investing Activities (2017 - 2025)

Arcus Biosciences has reported Cash from Investing Activities over the past 9 years, most recently at -$182.0 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$182.0 million for Q4 2025, down 456.86% from a year ago — trailing twelve months through Dec 2025 was $66.0 million (up 178.57% YoY), and the annual figure for FY2025 was $66.0 million, up 178.57%.
  • Cash from Investing Activities for Q4 2025 was -$182.0 million at Arcus Biosciences, down from $79.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for RCUS hit a ceiling of $137.0 million in Q2 2025 and a floor of -$268.0 million in Q1 2022.
  • Median Cash from Investing Activities over the past 5 years was $24.5 million (2022), compared with a mean of -$12.0 million.
  • Biggest five-year swings in Cash from Investing Activities: surged 13710.29% in 2021 and later plummeted 7259.51% in 2022.
  • Arcus Biosciences' Cash from Investing Activities stood at $18.8 million in 2021, then soared by 150.24% to $47.0 million in 2022, then crashed by 40.43% to $28.0 million in 2023, then surged by 82.14% to $51.0 million in 2024, then tumbled by 456.86% to -$182.0 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$182.0 million (Q4 2025), $79.0 million (Q3 2025), and $137.0 million (Q2 2025) per Business Quant data.